Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Novel vitamin D analogue with dissociation between immunosuppressive and hypercalcemic effects

Feb. 14, 2003

Avanir generates antibody to neutralize anthrax toxin

Feb. 14, 2003

Basiliximab immunoprophylaxis in the prevention of acute rejection after renal transplantation

Feb. 14, 2003

Encouraging results reported for Ontak in steroid-resistant acute GvHD

Feb. 13, 2003

MedImmune responds to FluMist complete response letter

Feb. 12, 2003

Cerus begins phase I trial of EBV vaccine

Feb. 10, 2003

Vical to develop DNA vaccine against CMV

Feb. 10, 2003

Potent, small-molecule IL-2/IL-2Ralpha antagonist designed at Sunesis

Feb. 7, 2003

Grant supports study of HE-2200 for treatment of traumatic shock

Feb. 5, 2003

Antex files initial IND for Tracvax

Feb. 5, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...